explore -WSS

explore

author：explore 2025-09-29 16:45:08 - browse：8884

NEW ORLEANS — For some patients suffering with certain blood cancers, CAR-T therapy can offer the tantalizing chance to end their disease with a single treatment.

But the immunotherapy takes time to manufacture, and patients often have to wait weeks to actually receive an infusion once they’re eligible. For some patients with especially aggressive cancer, they can die while waiting for the therapy to arrive.

That’s spurred CAR-T manufacturers to find ways to speed up manufacturing. The industry is testing newer — and possibly better — CAR-T cells that can be made more quickly. Researchers working with Novartis presented Phase 1 clinical trial data Sunday on a new CAR-T cell made with a rapid manufacturing process at the annual American Society of Hematology meeting.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： UnitedHealth’s Optum accused of antitrust violations in California

WSS

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

A daunting task: navigating dual Medicare, Medicaid eligibility

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

U.K. Biobank has 500,000 peoples' genome sequences available

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

The EPA's new lead rule: How one expert crunched the numbers

leisure time

explore

Wikipedia

Dobbs anniversary: the lost opportunity of abortion as health care

Disappointing trial forces Pfizer to pivot on obesity medicine plans

Affirmative action in medical school literally saved lives

U.K. Biobank has 500,000 peoples' genome sequences available

As demand for Covid shots wanes, Moderna seeks its next success

Does good food count as health care? Study aims to find out

Trump demands the U.S. pay no more for drugs than other countries … again

NYU radiologists take on the challenge of expensive MRI machines

Apple is now the first public company to be valued at $3 trillion

U.K. considers world's first use of meningitis vaccine to address gonorrhea

hotspot

Takeda, Janssen join wearable maker to measure scratching

Readout Newsletter: Bayer study halts, Carmot to IPO, and more

Organ aging and disease risk measured by new blood test

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

Will the market for weight loss drugs really reach $100 billion?

Ransomware attacks on hospitals: Study outlines patient impact

focus

entertainment

Wikipedia

explore